Infective endocarditis (IE), initially described more than 350 years ago, involves infection of
the endocardial surface of the heart. The clinical manifestations of IE can involve every …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

Device embolization is a rare complication of transcatheter structural heart interventions.
Although the majority of device embolizations can be treated in a semielective manner …

Background Currently, there is a paucity of information on surgical explantation after
transcatheter aortic valve replacement (TAVR). Objectives The purpose of this study was to …

Objectives: The aim of this study was to report the use trends and immediate and long-term
outcomes of a large cohort of patients who underwent redo surgery or transcatheter repair of …

Aims Paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) is
associated with increased morbidity and mortality. The effect of transcatheter interventions to …

Background Data regarding the safety and long-term effectiveness of percutaneous closure
of paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) are scarce …

Aims: The aim of the study was to assess the safety and efficacy of percutaneous closure of
paravalvular prosthetic leak (PVL) and to identify the predictors of procedural success and …

Hemolysis is an unintended sequel of temporary or permanent intracardiac devices.
However, limited data exist on the characteristics and treatment of hemolysis in patients with …

Background: Transcatheter closure of a symptomatic prosthetic paravalvular leak (PVL) is
feasible, but there is presently no conclusive evidence to show consistent efficacy. We …